Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression
RecruitingNCT07094789Phase: NAStarted 2025-07-11
Summary
The goal of this clinical trial is to evaluate the safety and initial effectiveness of Magnetic Resonance-guided focused ultrasound neuromodulation using the Next Generation Dome Helmet (NGDH) device
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Sunnybrook Health Sciences CentreToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07094789